Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive December 1, 2011	Europe's Transparency Directive Revisited The effect on pharma of the EU's Transparency Directive has been overly constraining, but will the mooted revisions offer any room to maneuver?
Pharmaceutical Executive May 1, 2011	Seeing Through the Transparency Directive The EU is largely powerless when it comes to policies over pharma pricing and reimbursement.
Pharmaceutical Executive June 1, 2011	A Lack of Information Why has the EU still not managed to update its rules on information about medicines?
Pharmaceutical Executive September 1, 2012	Patients Wade Into the Pricing Debate Europe's fiscal crisis is becoming a new rallying cry for patient groups, but regional unity is still elusive.
Pharmaceutical Executive September 1, 2005 Sarah Houlton	Global Report: Kids 'R' EU After years of delay, the European Parliament is ready to vote on pediatric-testing legislation.
Pharmaceutical Executive October 1, 2014	Eruptions on the Drug-Pricing Horizon in Europe An escalating political debate over pharma pricing and reimbursement nears the boiling point.
Pharmaceutical Executive April 1, 2011	Dalli's Formula Fails the Efficacy Test EU leadership on pharma policy leaves many wondering of the right man is at the helm.
Chemistry World November 28, 2008 Matt Wilkinson	EU claims pharma delaying tactics cost 3 billion euros Pharmaceutical manufacturers have been criticised by the EU competition commission for slowing the entry of generic medicines to the market.
Chemistry World October 29, 2007 Arthur Rogers	Deal to Allow Poor Nations Better Access to Cheap Drugs MEPs belatedly approved EU ratification of a 2005 World Trade Organization protocol on compulsory licensing -- potentially paving the way for developing countries to order generic drugs from manufacturers abroad without infringing patent rights.
Pharmaceutical Executive October 1, 2012 Peter O'Donnell	Richard Bergstrom -- Europe's Medicine Man The new head of the European Federation of Pharmaceutical Industries and Associations faces a Promethean challenge: selling the merits of costly science and innovation in an era of bristling competition, fiscal crisis, and declining demographics.
Pharmaceutical Executive February 1, 2006 Sarah Houlton	Global Report: Moving Towards Generic Biologics The European Medicines Agency hopes to complete its guidelines for the approval of biosimilar drugs early this year, paving the way for the approval of biogenerics - and a potential goldmine for the generics companies.
The Motley Fool February 8, 2011 Brian Orelli	A Few Extra Years of Sales? Yes, Please! An EU-Canadian proposal could help drugmakers.
Pharmaceutical Executive January 1, 2012	Here's to a Happier New Year? A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.
Chemistry World April 5, 2006 Arthur Rogers	Update: Europe Tightens Fluorinated Gas Restrictions A furious row between the European Parliament and the European Commission has stalled plans for further restrictions on use of fluorinated gases in the European Union.
Chemistry World July 10, 2009 Sarah Houlton	Branded drugs' competition-free days numbered Authorities in the US and Europe are to look carefully at the tactics pharmaceutical firms use to delay competition from generic versions of their branded drugs.
InternetNews July 6, 2005 Jim Wagner	European Parliament Rejects Software Patents After three years of debate, legislation to provide unified software patent protections across the EU is halted.
Chemistry World June 17, 2012 Andrew Turley	Lundbeck to lose 600 jobs The Danish company says it must cut jobs 'to mitigate increased pressure from healthcare reforms, generic competition and uncertainty regarding pricing and reimbursement in Europe'.
Chemistry World August 2, 2007 Victoria Gill	Europe Poised for a Surge in Generic Drugs The European Medicines Agency's Committee for Medicinal Products for Human use has recommended the approval of a schizophrenia treatment which is the first generic drug to be assessed under Europe's centralized procedure.
Pharmaceutical Executive September 1, 2014	Peril, Not Progress on Transatlantic Trade Deal Pharma hopes for a deal are fading as the once-hot TTIP talks seem to be on the fizzle in Europe.
Pharmaceutical Executive June 1, 2014	Hopes High as EU Heads Into Leadership Change The principal drug industry associations in Europe launched a call in mid-May for "an integrated European industrial policy for the pharmaceuticals sector."
The Motley Fool May 13, 2008 Brian Lawler	Sanofi Can't Shake the Generics A new threat to the pharmaceutical's top drug may have arrived.
Chemistry World August 17, 2015 Anthony King	Greek crisis puts pressure on pharmaceuticals Supplies of critical drugs to Greek pharmacies have become sparse and erratic as the economic crisis squeezes public spending
Chemistry World May 2006 Bea Perks	Editorial: Generics in the Dock The manufacturers of generic medicines in the U.K. must work harder to guard their good reputation. Or perhaps, manufacturers of generic medicines must work harder to counter their bad reputation.
Pharmaceutical Executive October 1, 2010	Euro Soul-Searching on Competition A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers.
Pharmaceutical Executive September 1, 2013	T-TIPing the Balance in Industry's Favor By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going.
Pharmaceutical Executive March 1, 2012	The Italian's Job After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director with great challenges ahead.
Pharmaceutical Executive February 1, 2009 Sarah Houlton	Reforms Offer Good News for Trade European Commission proposal loosens restrictions on drug packaging and information dissemination.
Chemistry World June 28, 2013 Helen Carmichael	European research funding deal on the Horizon The informal accord, reached on 25 June, just days before the end of the Irish presidency of the EU, offers a helping hand to scientists from poorer member states, in an attempt to balance the program's 'focus on excellence.'
Pharmaceutical Executive June 1, 2012	Europe Responds to Medical Device 'Crisis' A recent medical device controversy in France has pushed European health ministers to agree on a crisis management program for the troubled sector.
Chemistry World February 27, 2008 Arthur Rogers	European Institute of Technology to Open in 2010 A flurry of activity in Brussels and Strasbourg has cleared the way for a 2010 launch of the European Institute of Technology (EIT).
The Motley Fool May 28, 2008 Brian Lawler	A Little-Noticed Drug Rejection The EU temporarily blocks Sanofi and Bristol-Myers' shot at extending a drug's lifespan.
Chemistry World September 27, 2007 Arthur Rogers	European Institute Gets Green Light From MEPs Doubts persist over how the newly blessed European Institute of Technology will be funded. But already, EU member states are beginning to clamour for the kudos - and cash - they might attract by hosting the EIT governing board.
Chemistry World July 11, 2012	Europe-Wide Single Patent Stalls Again A single European patent is on the wish list of small innovative businesses.
Chemistry World February 18, 2014 Ned Stafford	GM maize poised for approval in Europe The European commission is on the verge of authorizing a genetically modified maize for cultivation after ministers from EU member nations last week failed to muster a large enough majority to reject the crop.
Chemistry World May 28, 2008 Arthur Rogers	EU strikes deal on Reach toxicity tests Under pressure from Members of the European Parliament, the European Commission has promised to speed up validation and authorization of toxicity tests that avoid the use of animals.
Pharmaceutical Executive July 1, 2011	Holy Surge of Enthusiasm! While Europe's EFPIA preaches about embracing change, much remains to be done to prove the adjustment in philosophy.
Chemistry World November 3, 2015 Ned Stafford	GM food and feed law falters in EU parliament Both GMO supporters and opponents applauded parliament's rejection of the proposed law.
Chemistry World April 19, 2013 Phillip Broadwith	Objections raised to GSK pay-for-delay deals The UK Office of Fair Trading has said that GlaxoSmithKline's deals to delay generic drugs infringed competition laws.
Pharmaceutical Executive December 1, 2008 Sarah Houlton	Animal Humanity The new EU directive looks to reduce, refine, and eventually replace animal testing.
Chemistry World February 6, 2009 Sean Milmo	EU clash over pollution permits The European Parliament and the Council of Ministers - the two arms of the European Union's legislature - appear to be heading towards a confrontation over a proposed law to further cut emissions from chemical and other plants.
Chemistry World October 25, 2007 Sean Milmo	New EU Legislation Would 'Ban 90 Per Cent of Insecticides' Agrochemical producers have warned that amendments to new European Union legislation on pesticides will lead to a drastic reduction in the crop protection agents available to farmers if they become law.
Chemistry World January 20, 2010 Phil Taylor	Screw tightens on pay-for-delay drug deals Scrutiny of the tactics used by pharmaceutical companies to delay the entry of generics onto the market is rising on both sides of the Atlantic amid claims that the practice is costing consumers billions every year.
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
Pharmaceutical Executive December 1, 2010	The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator The European Medicines Agency is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs.
Pharmaceutical Executive September 1, 2014 William Looney	Ireland's Celtic Tiger: Back on the Hunt Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products.
Pharmaceutical Executive November 1, 2006 Sarah Houlton	Global Report: 'Bout Time The European Union has been late to enter the fight against counterfeiting. Fed up, Parliament has passed a proposal designed to give its countries the nudge they need.
Pharmaceutical Executive July 1, 2014	Europe Gears Up to Attack Counterfeit Medicines -- But Only Some of Them Cross-sector partnership seeks support for a pan-European system to keep fake drugs out, but obstacles are many.
Chemistry World October 8, 2012 Phillip Broadwith	Europe gives generics merger the green flag Two of the top five global generic medicines manufactures, Watson and Actavis, have been given the go-ahead to merge by the European Commission.
The Motley Fool January 18, 2008 Brian Lawler	Wrong-Way Regulators in Europe European Union regulators raided operations of multiple large pharmaceutical companies looking for antitrust and anticompetitive actions in both the branded and generic sectors. They're looking in the wrong places.
Pharmaceutical Executive May 1, 2007 Sarah Houlton	Global Report: Pure and Simple The european union is set to overhaul the way it monitors drug safety to help make sense of a decentralized system that has been criticized for being ineffective. Will the EC's upcoming drug-safety plan be just what the doctor ordered or end up an indecent proposal?